🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

2 Capsule(s) Serving Size
90 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Pau d'Arco
180 mg
Yellow Dock
180 mg
130 mg
📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 130mg
100 mg
📊 Market median: 470.0mg (230 products) 📚 9 studies (Tier A: 3, B: 3)
This product: 100mg
Mullein
10 mg
Proprietary Enzyme Blend
38 mg

Other Ingredients

Cellulose Water Phytase

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (81% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions for use: Take 2 capsules, 3 times daily after meals or as directed.

⚠️ Warnings & Precautions

Keep out of reach of children.

Note: Consult your physician before using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Do not use if inner or outer seal is broken, torn, or missing.

🧪 Formulation Notes

pHBS pH Balancing System

Additional Information

To ensure freshness and potency, keep bottle tightly closed and store in a cool, dry place.

Product Details

UPC / SKU 6 97706 04561 1
DSLD Entry Date 2025-02-23
Product Type Other Combinations
Form Capsule
DSLD ID 327548
Data Updated 2026-04-11

Research Evidence

9 Research Sources
60 Avg Quality Score
5 Meta Analysis
2 Cochrane Review
1 Systematic Review
1 Rct
B Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
Cochrane Review The Cochrane database of systematic reviews
B Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.
Cochrane Review The Cochrane database of systematic reviews
B Evaluating traditional Chinese medicine (TCM) Jie Geng and Huang Qi combination on reducing surgical site infections in colorectal cancer surgeries: A systematic review and meta-analysis
Meta Analysis International wound journal 2024
B Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
Rct BMJ supportive & palliative care 2025
B Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation
Meta Analysis Renal failure 2025
B Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: An updated systematic review and meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024
C Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review
Systematic Review Metabolic brain disease 2020
C Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
Meta Analysis Integrative cancer therapies 2025
C The Effect of Astragalus on Humoral and Cellular Immune Response: A Systematic Review and Meta-Analysis of Human Studies
Meta Analysis Complementary medicine research 2023
View all evidence for Astragalus →

Compare Similar Products

View all Astragalus products →